If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
60.00    0.00 (0.00%)
Bid:
57.20
Ask:
60.00
Spread: 2.80 (4.895%)
Market Cap: £48.86m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Acquisition

29 Apr 2005 07:00

Flomerics Group PLC29 April 2005 29 April 2005 Flomerics Group plc ("the Company") Acquisition of Microelectronics Research & Development Limited Flomerics Group plc ("Flomerics" or "the Company"), supplier of virtualprototyping analysis software for the electronics industries announces theacquisition of the entire share capital of Microelectronics Research &Development Limited ("MicReD") for a maximum total consideration ofapproximately €2.1 million. Initial consideration is approximately €898,000, ofwhich €653,000 is payable in cash, the remaining €245,000 is satisfied by theissue of 250,663 Ordinary Shares of 1 pence each in the Company ("OrdinaryShares"), 80% now and 20% after 1 year. The deferred consideration is dependenton the financial performance of MicReD in 2005 and 2006. MicReD is a Hungarian based company and was formed in 1997 as a spin-off fromBudapest University of Technology. MicReD employs 13 people all located inBudapest and is led by the Chief Executive Officer, Marta Rencz. The managementteam of MicReD will all remain with the business. Its primary product is theT3Ster (pronounced Trister) - instrumentation and software used for measuringthe thermal performance of chip packages. Existing customers include Philips,Infineon, ST Microelectronics, Intel, Samsung and IBM. In the year to 31December 2004 MicReD had audited income of approximately €538,000 and made aprofit before tax of €288,000. In the previous year the unaudited turnover wasapproximately €123,000. The net assets at 31 December 2004 were €234,000. The semiconductor companies that make up the main target market for the T3Sterrepresent a significant, and strategically important, sector of the Flomerics'customer base. The use of the T3Ster enables them to evaluate and improve thethermal performance of chip-package designs - often alongside the complementaryuse of Flomerics' thermal analysis software. Just as the need for Flomerics'products is driven by the increasing miniaturisation and thermal densities ofelectronics devices - so exactly the same trends are driving the need for theT3Ster. The acquisition is thus strongly synergistic with Flomerics' current corebusiness, and represents a significant step for Flomerics towards providing acomplete thermal-design solution for its customers. In order to satisfy part of the initial consideration application has been madefor 200,530 new ordinary shares of 1p each to be admitted to trading on AIM witheffect from 5 May 2005. Following admission the issued share capital of theCompany will be 14,847,110 Ordinary Shares of 1p each. Commenting on the transaction David Tatchell, Flomerics' Chief Executive said "This is an important first step in delivering on our strategy of growing theCompany by acquisition in a way that complements our organic growth plans. I amdelighted to welcome into the Group the world-leading expertise that the MicReDteam bring. The T3Ster has many applications in markets where Flomerics is wellestablished, and we believe therefore that there is great potential to expandthe business." Marta Rencz said "We are very excited to be a part of the Flomerics group.Flomerics is the acknowledged standard setter in this field and theirinfrastructure will enable us to maximise the potential of our products." For further information please contact: David Tatchell Chief Executive 020 8487 3000Chris Ogle Finance Director & Company Secretary Buchanan Communications 020 7466 5000Tim Thompson / Nicola Cronk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Jun 20087:00 amRNSOffer Update
2nd Jun 20087:00 amRNSStatement re Unsolicited Offe
30th May 20084:40 pmRNSOffer Update
30th May 20082:36 pmRNSRule 2.10 Announcement
30th May 20089:30 amRNSAdditional Listing
29th May 20081:41 pmRNSResult of AGM
28th May 20082:15 pmRNSResult of AGM
28th May 20082:11 pmRNSPosting of Defence Document
28th May 20087:00 amRNSOffer Update
27th May 20087:00 amRNSQ1 Trading Update
19th May 20081:30 pmRNSStatement
19th May 20087:00 amRNSOffer Document Posted
16th May 20087:00 amRNSAnnual General Meeting
13th May 20081:20 pmRNSRule 8.3-Flomerics Plc
13th May 200812:45 pmRNSRule 8.3- Flomerics Group Plc
13th May 20089:35 amRNSRule 2.10 and TVR
12th May 20081:49 pmRNSAdditional Listing
9th May 20088:48 amRNSOffer Rejection
9th May 20088:37 amRNSOffer for Flomerics Group plc
30th Apr 20084:23 pmRNSHolding(s) in Company
30th Apr 200811:14 amRNSAdditional Listing
29th Apr 20087:01 amRNSFinal Results
18th Apr 200812:06 pmRNSAdditional Listing
15th Apr 200810:41 amRNSDirectorate Change
10th Apr 20082:51 pmRNSHolding(s) in Company
10th Apr 20087:00 amRNSTotal Voting Rights
27th Mar 20087:02 amRNSUpdate
19th Mar 200812:58 pmRNSHolding(s) in Company
19th Mar 200810:11 amRNSHolding(s) in Company
18th Mar 20083:59 pmRNSAdditional Listing
18th Mar 20087:30 amRNSHolding(s) in Company
17th Mar 200811:27 amRNSHolding(s) in Company
14th Mar 20083:17 pmRNSHolding(s) in Company
3rd Mar 20087:00 amRNSAdditional Listing
28th Feb 20082:37 pmRNSDirector/PDMR Shareholding
27th Feb 200810:50 amRNSDirector/PDMR Shareholding
22nd Feb 20085:31 pmRNSDirector/PDMR Shareholding
21st Feb 200812:19 pmRNSGrant of Options
9th Jan 20087:00 amRNSTrading Statement
20th Dec 20077:02 amRNSDisposal
19th Dec 200712:36 pmRNSHolding(s) in Company
3rd Dec 200712:00 pmRNSDirectorate Change
27th Sep 200711:23 amRNSAdditional Listing
27th Sep 20079:41 amRNSHolding(s) in Company
19th Sep 20077:02 amRNSInterim Results
14th Sep 20075:03 pmRNSHolding(s) in Company
15th Aug 20072:27 pmRNSAIM Rule 26
13th Jul 20077:00 amRNSTrading Statement
12th Jul 20075:07 pmRNSHolding(s) in Company
5th Jul 200711:41 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.